| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8587110 | Clinical Nutrition ESPEN | 2018 | 7 Pages |
Abstract
Although therapeutic approaches for ADHD have been essentially pharmacologic, in recent years several studies were performed to investigate the role of nutrition, especially omega 3 polyunsaturated fatty acid (omega 3-PUFA), in the development and treatment of this disorder. In this review, the authors gathered the most relevant evidence regarding omega 3-PUFA, mainly docosahexaenoic acid, as coadjutant or as a single therapy, in the management of ADHD symptoms. The authors also reviewed this disorder's current medical and therapeutic features.
Related Topics
Health Sciences
Medicine and Dentistry
Critical Care and Intensive Care Medicine
Authors
Renata Ramalho, Ana Colaço Pereira, Filipa Vicente, Paula Pereira,